- Version
- Download 1896
- File Size 0.00 KB
- File Count 1
- Create Date February 10, 2022
- Last Updated December 15, 2022
AAV gene therapy for Tay-Sachs disease
Share This Story, Choose Your Platform!
About the Author: Michael Foley
©2025 National Tay-Sachs & Allied Diseases Association | Privacy Policy | All Rights Reserved | Built by eLearnza
National Tay-Sachs & Allied Diseases Association (NTSAD) leads the worldwide fight to treat and cure Tay-Sachs, Canavan, GM1, and Sandhoff diseases by driving research, forging collaboration, and fostering community. Supporting families is the center of everything we do.
The National Tay-Sachs & Allied Diseases Association (NTSAD) leads the worldwide fight to treat and cure Tay-Sachs, Canavan, GM1, and Sandhoff diseases by driving research, forging collaboration, and fostering community. Supporting families is the center of everything we do.
Community Connections
Get the latest news from NTSAD about our Community, the research that provides hope, and what is happening in the world of rare disease.
2001 Beacon Street, Suite 204
Boston, MA 02135
(617) 277-4463
info@ntsad.org
Tax ID
#13-1912877
National Tay-Sachs & Allied Diseases Association
2001 Beacon Street, Suite 204, Boston, MA 02135
(617) 277-4463 | info@ntsad.org
Tax ID
#13-1912877